TLRY Profile
- Sector: Process Industries
- Industry: Agricultural Commodities/Milling
- Employees: 1646
Tilray, Inc. engages in the research, cultivation, production, and distribution of medical cannabis and cannabinoids. The Company is focused on medical cannabis research, cultivation, processing and distribution of cannabis products worldwide. Its products include dried cannabis and cannabis extracts. It operates through the following segments: Cannabis and Hemp. The Cannabis segment sales consists of adult-use, medical and bulk sales of cannabis under regulated licenses and sold to retail, wholesale, pharmacy, government, and direct to patient. The Hemp segment sales consist of hemp seed, hemp foods, board spectrum hemp extract containing CBD which are sold in an unlicensed operation and sold to retail, wholesale and direct to consumers. The company was founded on January 24, 2018 and is headquartered in Nanaimo, Canada.
[bbp-topic-index] [bbp-topic-form]Recent News
Top 3 Cannabis Winners of Today
Cannabis sector continues to bounce after Aurora leading the pack with better than expected earnings rally, Aurora is yet again up over 35% for the …
Expect at least a dozen pot companies to go bankrupt in 2020
According to Tilray’s chief executive officer the COVID-19 pandemic is likely to force at least a dozen cannabis companies to file for bankruptcy. Most companies …
Tilray, Inc. Reports First Quarter 2020 Financial Results
Quarterly Revenue Increased 126% to $52.1 Million (C$70.7 Million) Compared to the First Quarter of 2019 and 11% Sequentially from the Fourth Quarter of 2019 …
- Canopy Rivers Announces Results of Annual General and Special Meeting of Shareholders
- Meta Growth Announces Filing of Management Information Circular in Connection with Proposed Arrangement with High Tide
- MediPharm Labs Expands Denmark Revenue Opportunity, Enters New Supply Agreement with DanCann Pharma
- Supreme Cannabis Announces Financial Results for Q4 and Full-year 2020
- Red White & Bloom Brands Inc. Announces Closing of $25 Million Bought Deal Offering of Units, Including Full Exercise of the Over-Allotment Option
- Numinus Commences Psilocybe Mushroom Cultivation at its Health Canada Licensed Laboratory
- Zenabis Announces Closing of Public Offering of Units
- Mindleap Health Announces The Launch of The World’s First Telehealth Platform For Psychedelic Integration
- VIVO Cannabis™ Completes Debenture Refinancing
- Meta Growth Announces Opening of New Cannabis Retail Store in Winnipeg
All posts made on this website are provided for information purposes only. None of the information here is intended as investment advice, as an offer or solicitation of an offer to buy or sell, or as a recommendation, endorsement, or sponsorship of any security, Company, or fund. Before making an investment decision, you should seek the advice of a qualified and registered securities professional. Candlr is not receiving payment or commissions from companies for shared content on Candlr website unless its specified. View full disclaimer HERE.